General Biologicals Corporation (TPEX:4117)

General Biologicals Statistics

Total Valuation

TPEX:4117 has a market cap or net worth of TWD 742.07 million. The enterprise value is 3.06 billion.

Market Cap	742.07M
Enterprise Value	3.06B

Important Dates

The next estimated earnings date is Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4117 has 60.83 million shares outstanding.

Current Share Class	60.83M
Shares Outstanding	60.83M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.34%
Owned by Institutions (%)	1.64%
Float	34.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.95
PB Ratio	4.73
P/TBV Ratio	7.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.57
EV / Sales	12.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.76

Financial Position

The company has a current ratio of 1.32, with a Debt / Equity ratio of 16.02.

Current Ratio	1.32
Quick Ratio	0.89
Debt / Equity	16.02
Debt / EBITDA	n/a
Debt / FCF	-3.91
Interest Coverage	-9.00

Financial Efficiency

Return on equity (ROE) is -87.71% and return on invested capital (ROIC) is -5.52%.

Return on Equity (ROE)	-87.71%
Return on Assets (ROA)	-4.10%
Return on Invested Capital (ROIC)	-5.52%
Return on Capital Employed (ROCE)	-6.84%
Revenue Per Employee	3.10M
Profits Per Employee	-3.01M
Employee Count	81
Asset Turnover	0.08
Inventory Turnover	2.72

Taxes

Income Tax	-292,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.37% in the last 52 weeks. The beta is 0.58, so TPEX:4117's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-37.37%
50-Day Moving Average	12.61
200-Day Moving Average	15.39
Relative Strength Index (RSI)	38.63
Average Volume (20 Days)	313,153

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4117 had revenue of TWD 251.38 million and -243.60 million in losses. Loss per share was -4.07.

Revenue	251.38M
Gross Profit	8.67M
Operating Income	-219.61M
Pretax Income	-245.60M
Net Income	-243.60M
EBITDA	-182.84M
EBIT	-219.61M
Loss Per Share	-4.07

Balance Sheet

The company has 195.76 million in cash and 2.51 billion in debt, with a net cash position of -2.32 billion or -38.11 per share.

Cash & Cash Equivalents	195.76M
Total Debt	2.51B
Net Cash	-2.32B
Net Cash Per Share	-38.11
Equity (Book Value)	156.90M
Book Value Per Share	2.57
Working Capital	106.69M

Cash Flow

In the last 12 months, operating cash flow was -186.47 million and capital expenditures -456.47 million, giving a free cash flow of -642.94 million.

Operating Cash Flow	-186.47M
Capital Expenditures	-456.47M
Free Cash Flow	-642.94M
FCF Per Share	-10.57

Margins

Gross margin is 3.45%, with operating and profit margins of -87.36% and -96.90%.

Gross Margin	3.45%
Operating Margin	-87.36%
Pretax Margin	-97.70%
Profit Margin	-96.90%
EBITDA Margin	-72.73%
EBIT Margin	-87.36%
FCF Margin	n/a

Dividends & Yields

TPEX:4117 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-32.83%
FCF Yield	-86.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:4117 has an Altman Z-Score of -0.12 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.12
Piotroski F-Score	3